RYCFX Holdings Information

RYCFX is a mutual fund with a total of 73 individual holdings. The top holdings are AbbVie stock at 8.15%, Amgen at 5.04%, Gilead Sciences at 4.48%, Vertex Pharmaceuticals at 4.31%, and Regeneron Pharmaceuticals at 2.93%.

Total Holdings

Top 10 Percentage

36.17%

Asset Class

Equity

Fund Category

Health

Assets

123.77M

Forward PE Ratio

17.48

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ABBV	AbbVie Inc.	8.15%	44,415
2	AMGN	Amgen Inc.	5.04%	19,065
3	GILD	Gilead Sciences, Inc.	4.48%	48,654
4	VRTX	Vertex Pharmaceuticals Incorporated	4.31%	11,897
5	REGN	Regeneron Pharmaceuticals, Inc.	2.93%	6,432
6	RVMD	Revolution Medicines, Inc.	2.47%	18,109
7	ALNY	Alnylam Pharmaceuticals, Inc.	2.35%	10,721
8	ONC	BeOne Medicines AG	2.17%	10,427
9	MRNA	Moderna, Inc.	2.14%	41,976
10	BIIB	Biogen Inc.	2.12%	13,465
11	NTRA	Natera, Inc.	2.11%	10,672
12	RPRX	Royalty Pharma plc	2.01%	49,095
13	ILMN	Illumina, Inc.	1.93%	15,058
14	INSM	Insmed Incorporated	1.79%	22,998
15	UTHR	United Therapeutics Corporation	1.72%	4,350
16	GH	Guardant Health, Inc.	1.72%	15,671
17	ROIV	Roivant Sciences Ltd.	1.66%	64,115
18	INCY	Incyte Corporation	1.61%	19,518
19	VTRS	Viatris Inc.	1.55%	133,745
20	NBIX	Neurocrine Biosciences, Inc.	1.52%	12,363
21	ARGX	argenx SE	1.48%	2,181
22	JAZZ	Jazz Pharmaceuticals plc	1.41%	8,037
23	BBIO	BridgeBio Pharma, Inc.	1.38%	25,399
24	IONS	Ionis Pharmaceuticals, Inc.	1.35%	23,328
25	CYTK	Cytokinetics, Incorporated	1.35%	21,687

Showing 25 of 73 holdings

Subscribe to see the full list

Activate Now

As of Jun 30, 2026